Evidence map›Paper›PMID 30230971›Full record

ArticleJournal of toxicology and environmental health. Part A2018

Analysis of autoantibody profiles in two asbestiform fiber exposure cohorts.

Jean C Pfau, Christopher Barbour, Brad Black, Kinta M Serve, Marvin J Fritzler

Open access · greenAbstract read
In one paragraph

Article in Journal of toxicology and environmental health. Part A, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Autoantibodies and cancer among asbestos-exposed cohorts in Western Australia.Journal of toxicology and environmental health. Part A · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Jean C Pfaua Department of Microbiology & Immunology , Montana State University , Bozeman , MT , US.ORCID 0000-0002-1249-7195
Christopher Barbourb Statistical Consulting and Research Services , Montana State University , Bozeman , MT , US.
Brad Blackc Center for Asbestos Related Diseases , Libby , MT , US.
Kinta M Served Department of Biological Sciences , Idaho State University , Pocatello , ID , US.
Marvin J Fritzlere Cumming School of Medicine , University of Calgary , Calgary , Canada.
Montana State University · USCenter for Asbestos Related Disease · USIdaho State University · USUniversity of Calgary · CA

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Research Core (Developmental Research Project Program)P20GM103474 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Jeffrey Good · 2012 to 2026
$60.0M
Tracking and EvaluationU54GM104944 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI ZHU, YILIANG · 2013 to 2023
$39.6M
Libby Epidemiology Research ProgramR01TS000099 · TS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FLORES, RAJA M. · 2009 to 2013
$4.8M
ATSDR CDC HHS R01 TS000099NCATS NIH HHS UL1 TR002319NIGMS NIH HHS P20 GM103474NIGMS NIH HHS U54 GM104944
6 · The paper itself

Abstract

An increased risk for Systemic Autoimmune Diseases (SAID) was reported in the population of Libby, Montana, where extensive exposure to asbestiform amphiboles occurred through mining and use of asbestiform fiber-laden vermiculite. High frequencies of antinuclear autoantibodies (ANA) were detected in individuals and mice exposed to Libby Asbestiform Amphiboles (LAA). Among the 6603 individuals who have undergone health screening at the Center for Asbestos Related Diseases (CARD, Libby MT), the frequencies of rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis, and systemic sclerosis are significantly higher than expected prevalence in the United States. While these data support the hypothesis that LAA can trigger autoimmune responses, evidence suggests that chrysotile asbestos does not. Serological testing was therefore performed in subjects exposed to LAA or predominantly chrysotile (New York steamfitters) using multiplexed array technologies. Analyses were performed in order to determine a) autoantibody profiles in each cohort, and b) whether the two populations could be distinguished through predictive modeling. Analysis using perMANOVA testing confirmed a significant difference between autoantibody profiles suggesting differential pathways leading to autoantibody formation. ANA were more frequent in the LAA cohort. Specific autoantibodies more highly expressed with LAA-exposure were to histone, ribosomal P protein, Sm/Ribonucleoproteins, and Jo-1 (histidyl tRNA synthetase). Myositis autoantibodies more highly expressed in the LAA cohort were Jo-1, PM100, NXP2, and Mi2a. Predictive modeling demonstrated that anti-histone antibodies were most predictive for LAA exposure, and anti-Sm was predictive for the steamfitters' exposure. This emphasizes the need to consider fiber types when evaluating risk of SAID with asbestos exposure.

Indexed as

AdultAgedAged, 80 and overAsbestos, AmphiboleAsbestos, SerpentineAutoantibodiesCohort StudiesCross-Sectional StudiesFemaleHumansMaleMiddle AgedMontanaNew YorkOccupational ExposureYoung AdultAsbestos, AmphiboleAsbestos, SerpentineAutoantibodiesamphiboleAsbestosautoantibodieschrysotilelibby montana

Identifiers

PMID30230971
PMCPMC6336195
OpenAlexW2891282608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.